Showing 1411-1420 of 7030 results for "".
Part 7, 1726 nm lasers: When a patient doesn’t improve: Doctors discuss “pearls” of wisdom
https://practicaldermatology.com/series/scientifically-speaking/1726-nm-lasers-five-dermatologists-discuss-the-lasers-benefits-and-drawbacks-for-treating-acne-and-other-skin-conditions/24345/Chapter 7 of 7: David Goldberg, MD, from New York, Emil Tanghetti, MD, from Sacramento, Jordan Wang, MD, from Philadelphia and New York and Naz Saedi, MD, from Philadelphia talk about when a patient doesn’t improve: Doctors discuss “pearls” of wisdom.The State of Private Equity in 2024: Impact on the Practice of Dermatology
https://practicaldermatology.com/columns/practice-management/state-private-equity-2024-impact-practice-dermatology/27173/Physician Growth Partners recently published a white paper, “State of Dermatology Private Equity,” that evaluated market trends, strategies, and more. Practical Dermatology® spoke exclusively with CEO Michael Kroin about how the evolution of private equity is impacting the everyday practitioner andChronic Hand Eczema
https://practicaldermatology.com/programs/practical-dermatology-atopic-dermatitis/chronic-hand-eczema/29146/Dr. Raj Chovatiya, Clinical Associate Professor of Medicine at Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research, talks about chronic hand eczema.Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
https://practicaldermatology.com/series/dermwire-tv/study-examines-association-between-childhood-bmi-and-risk-of-developing-imsds/27004/In this week's DermwireTV, a new study examines the relationship between childhood BMI and skin diseases; phase 3 data sheds new light on dupilumab’s effect on inflammatory biomarkers in pediatric AD patients; and the president and CEO of Evolus discusses trends in the injectables market.New AD Guidelines: A Paradigm Shift in AD Care
https://practicaldermatology.com/topics/atopic-dermatitis/new-ad-guidelines-a-paradigm-shift-in-ad-care/24024/Peter Lio, MD, reviews an updated model of clinical guidance in a rapidly changing healthcare environment.Biologics in Psoriasis: The Next Generation
https://practicaldermatology.com/topics/psoriasis/biologics-in-psoriasis-the-next-generation/20807/Get familiar with the IL-23 monoclonal antibodies.Science of Skincare Summit 2024: On the FDA Approval of Emrosi for Rosacea
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-on-the-fda-approval-of-emrosi-for-rosacea/29276/At the Science of Skincare Summit in Austin, Practical Dermatology caught up with Chief Medical Editor Neal Bhatia, MD, and James Del Rosso, DO, a dermatologist and Editor in Chief of Clinical Dermatology at the Journal of Clinical and Aesthetic Dermatology (JCAD), who shared insights and thoughts oPsleep: Psoriasis and Sleep
https://practicaldermatology.com/topics/psoriasis/psleep-psoriasis-and-sleep/29075/The “invisible” impacts of psoriasis are those not directly seen on examination. These include itch, pain, fatigue and sleep dysfunction, which may be improved by our systemic therapies. However, there is a gap between the patients’ reporting of these experienced invisible impacts and their physiciaHidradenitis Suppurativa: A Patient’s Perspective
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-a-patients-perspective/27171/Adam Friedman, MD, FAAD, presents a first-hand account of a patient living with hidradenitis suppurativa (HS).Don’t Surround Yourself With Yourself…
https://practicaldermatology.com/topics/editorial/dont-surround-yourself-with-yourself/27152/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, challanges collgeaues to surround each other with diverse perspectives and celebrate different points of view in their daily work as dermatologists and caregivers.